These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8290659)

  • 1. Central serotonergic changes following antidepressant treatment: a neuroendocrine assessment.
    Leatherman ME; Ekstrom RD; Corrigan M; Carson SW; Mason G; Golden RN
    Psychopharmacol Bull; 1993; 29(2):149-54. PubMed ID: 8290659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal neuroendocrine responsivity to clomipramine in depression.
    Golden RN; Ruegg R; Brown TM; Haggerty J; Garbutt JC; Pedersen CA; Evans DL
    Psychopharmacol Bull; 1990; 26(3):317-20. PubMed ID: 2125736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study of serotonergic function in depression.
    Golden RN; Heine AD; Ekstrom RD; Bebchuk JM; Leatherman ME; Garbutt JC
    Neuropsychopharmacology; 2002 May; 26(5):653-9. PubMed ID: 11927190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers.
    Stahl SM; Hauger RL; Rausch JL; Fleishaker JC; Hubbell-Alberts E
    Clin Neuropharmacol; 1993; 16 Suppl 3():S19-31. PubMed ID: 8131152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.
    Golden RN; Ekstrom D; Brown TM; Ruegg R; Evans DL; Haggerty JJ; Garbutt JC; Pedersen CA; Mason GA; Browne J
    Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenfluramine challenge test as a predictor of outcome in major depression.
    Malone KM; Thase ME; Mieczkowski T; Myers JE; Stull SD; Cooper TB; Mann JJ
    Psychopharmacol Bull; 1993; 29(2):155-61. PubMed ID: 7507256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mid-term effects of serial sleep deprivation therapy implemented in cognitive-behavioral treatment on the neuroendocrine response to clomipramine in patients with major depression.
    Kundermann B; Strate P; Hemmeter-Spernal J; Huber MT; Krieg JC; Lautenbacher S
    J Psychiatr Res; 2009 Apr; 43(7):711-20. PubMed ID: 18930473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M; Wilkins A; Werstiuk ES; Steiner M
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine?
    Spreux-Varoquaux O; Gailledreau J; Vanier B; Bothua D; Plas J; Chevalier JF; Advenier C; Pays M; Brion S
    Biol Psychiatry; 1996 Sep; 40(6):465-73. PubMed ID: 8879466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity.
    Lykouras L; Markianos M; Hatzimanolis Y
    Neuropsychobiology; 2011; 63(2):77-81. PubMed ID: 21178381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prolactin, depression and antidepressive agents. Review of the literature].
    Ben Hadj Ali B
    Encephale; 1987; 13(3):101-12. PubMed ID: 3297633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of postnatal isolation rearing and antidepressant treatment on the density of serotonergic and noradrenergic axons and depressive behavior in rats.
    Kuramochi M; Nakamura S
    Neuroscience; 2009 Sep; 163(1):448-55. PubMed ID: 19524023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine.
    Vázquez-Palacios G; Bonilla-Jaime H; Velázquez-Moctezuma J
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):39-46. PubMed ID: 15610943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
    Rajewska J; Rybakowski JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
    Hellweg R; Ziegenhorn A; Heuser I; Deuschle M
    Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):172-6. PubMed ID: 12242578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients.
    Golden RN; Hsiao JK; Lane E; Ekstrom D; Rogers S; Hicks R; Potter WZ
    Psychiatry Res; 1990 Jan; 31(1):39-47. PubMed ID: 2156276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECT treatment does not enhance neuroendocrine responses to serotonergic challenge.
    Manji HK; Hsiao JK; Risby ED; Osman OT; Rudorfer MV; Potter WZ
    J Psychopharmacol; 1992 Jan; 6(4):501-8. PubMed ID: 22291398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.